FI118626B - Kooloniin annettava lääkekoostumus - Google Patents

Kooloniin annettava lääkekoostumus Download PDF

Info

Publication number
FI118626B
FI118626B FI965154A FI965154A FI118626B FI 118626 B FI118626 B FI 118626B FI 965154 A FI965154 A FI 965154A FI 965154 A FI965154 A FI 965154A FI 118626 B FI118626 B FI 118626B
Authority
FI
Finland
Prior art keywords
drug
colon
coating
delivery composition
drug delivery
Prior art date
Application number
FI965154A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI965154A (fi
FI965154A0 (fi
Inventor
Peter Watts
Original Assignee
Archimedes Dev Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Archimedes Dev Ltd filed Critical Archimedes Dev Ltd
Publication of FI965154A0 publication Critical patent/FI965154A0/fi
Publication of FI965154A publication Critical patent/FI965154A/fi
Application granted granted Critical
Publication of FI118626B publication Critical patent/FI118626B/fi

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4891—Coated capsules; Multilayered drug free capsule shells

Landscapes

  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
FI965154A 1994-06-21 1996-12-20 Kooloniin annettava lääkekoostumus FI118626B (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
GB9412394 1994-06-21
GB9412394A GB9412394D0 (en) 1994-06-21 1994-06-21 Colonic drug delivery composition
GB9501458 1995-06-21
PCT/GB1995/001458 WO1995035100A1 (fr) 1994-06-21 1995-06-21 Composition destinee a administrer un medicament dans le colon

Publications (3)

Publication Number Publication Date
FI965154A0 FI965154A0 (fi) 1996-12-20
FI965154A FI965154A (fi) 1997-02-20
FI118626B true FI118626B (fi) 2008-01-31

Family

ID=10757052

Family Applications (1)

Application Number Title Priority Date Filing Date
FI965154A FI118626B (fi) 1994-06-21 1996-12-20 Kooloniin annettava lääkekoostumus

Country Status (14)

Country Link
US (2) US6228396B1 (fr)
EP (1) EP0810857B1 (fr)
JP (1) JP2986217B2 (fr)
AT (1) ATE204751T1 (fr)
AU (1) AU688060B2 (fr)
CA (1) CA2193481C (fr)
DE (1) DE69522475T2 (fr)
DK (1) DK0810857T3 (fr)
ES (1) ES2162922T3 (fr)
FI (1) FI118626B (fr)
GB (1) GB9412394D0 (fr)
NO (1) NO315686B1 (fr)
PT (1) PT810857E (fr)
WO (1) WO1995035100A1 (fr)

Families Citing this family (76)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5686106A (en) * 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
GB9620709D0 (en) * 1996-10-04 1996-11-20 Danbiosyst Uk Colonic delivery of weak acid drugs
CA2271560C (fr) * 1996-11-15 2003-09-23 Mayo Foundation For Medical Education And Research Forme galenique pharmaceutique concue pour etre administree dans le colon
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same
DE19732903A1 (de) 1997-07-30 1999-02-04 Falk Pharma Gmbh Pellet-Formulierung zur Behandlung des Intestinaltraktes
US7153845B2 (en) * 1998-08-25 2006-12-26 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
US8765177B2 (en) * 1997-09-12 2014-07-01 Columbia Laboratories, Inc. Bioadhesive progressive hydration tablets
GB9800912D0 (en) * 1998-01-17 1998-03-11 Danbiosyst Uk New composition
KR20010040646A (ko) * 1998-02-09 2001-05-15 블로닉, 조엘 위장관의 만성 염증성 질환의 치료방법
US7022683B1 (en) * 1998-05-13 2006-04-04 Carrington Laboratories, Inc. Pharmacological compositions comprising pectins having high molecular weights and low degrees of methoxylation
AU757343B2 (en) * 1998-09-28 2003-02-20 Capsugel Belgium Nv Enteric and colonic delivery using HPMC capsules
DE19923817A1 (de) * 1999-05-18 2000-11-23 Roland Bodmeier Kapsel mit kontrollierter Wirkstofffreisetzung
ATE314091T1 (de) 1999-06-09 2006-01-15 Mochida Pharm Co Ltd System für wirkstofffreisetzung im unteren verdauungstrakt
US6340473B1 (en) 1999-07-07 2002-01-22 R.P. Scherer Technologies, Inc. Film forming compositions comprising modified starches and iota-carrageenan and methods for manufacturing soft capsules using same
IT1318625B1 (it) * 2000-07-14 2003-08-27 Roberto Valducci Formulazioni farmaceutiche solide orali a rilascio multifasicoph-dipendente.
US6908609B2 (en) 2000-11-20 2005-06-21 Dow Global Technologies Inc. In vivo use of water absorbent polymers
US7494669B2 (en) * 2001-02-28 2009-02-24 Carrington Laboratories, Inc. Delivery of physiological agents with in-situ gels comprising anionic polysaccharides
US6777000B2 (en) * 2001-02-28 2004-08-17 Carrington Laboratories, Inc. In-situ gel formation of pectin
US6645946B1 (en) 2001-03-27 2003-11-11 Pro-Pharmaceuticals, Inc. Delivery of a therapeutic agent in a formulation for reduced toxicity
EP1383516B1 (fr) 2001-03-27 2011-11-09 Pro-Pharmaceuticals, Inc. Co-administration d'un polysaccharide avec un agent chimiotherapeutique permettant le traitement du cancer
JP2005537244A (ja) * 2002-06-28 2005-12-08 ナステック・ファーマシューティカル・カンパニー・インコーポレーテッド 療法化合物の粘膜搬送を増進させるための、上皮接合部接着分子の生理機能を調節する組成物および方法
US8404717B2 (en) * 2002-10-15 2013-03-26 Celgene Corporation Methods of treating myelodysplastic syndromes using lenalidomide
US11116782B2 (en) 2002-10-15 2021-09-14 Celgene Corporation Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
US8404716B2 (en) * 2002-10-15 2013-03-26 Celgene Corporation Methods of treating myelodysplastic syndromes with a combination therapy using lenalidomide and azacitidine
TWI355276B (en) * 2003-01-14 2012-01-01 Akira Tsuji Gastrointestinal absorption enhancer mediated by p
MXPA05011644A (es) * 2003-04-30 2005-12-15 Nastech Pharm Co Subexpresion de claudinas como marcadores de metastasis de tumor.
US20050043272A1 (en) * 2003-07-11 2005-02-24 Pro-Pharmaceuticals, Inc. Compositions and methods for hydrophobic drug delivery
US7737133B2 (en) 2003-09-03 2010-06-15 Agi Therapeutics Ltd. Formulations and methods of treating inflammatory bowel disease
US7825106B2 (en) 2003-09-03 2010-11-02 Agi Therapeutics Ltd. Modified release formulations and methods of treating inflammatory bowel disease
US20050053664A1 (en) * 2003-09-08 2005-03-10 Eliezer Zomer Co-administration of a polysaccharide with a chemotherapeutic agent for the treatment of cancer
US20050129679A1 (en) * 2003-12-15 2005-06-16 Nastech Pharmaceutical Company Inc. Method for opening tight junctions
US20070078109A1 (en) * 2004-02-13 2007-04-05 David Platt Compositions and methods used to treat acne and candida
US20040224019A1 (en) * 2004-03-03 2004-11-11 Adi Shefer Oral controlled release system for targeted drug delivery into the cell and its nucleus for gene therapy, DNA vaccination, and administration of gene based drugs
EP1773128A2 (fr) * 2004-08-02 2007-04-18 Pro-Pharmaceuticals, Inc. Compositions et procedes permettant d'ameliorer l'efficacite d'une chimiotherapie a l'aide de cytotoxines microbiennes
GB0421121D0 (en) * 2004-09-22 2004-10-27 Natrocell Technologies Ltd Composite rodenticide
GB0517957D0 (en) 2005-09-03 2005-10-12 Morvus Technology Ltd Method of combating infection
GB0526552D0 (en) 2005-12-29 2006-02-08 Morvus Technology Ltd New use
US7964215B1 (en) 2006-01-24 2011-06-21 Emet Pharmaceuticals, LLC Delayed release dosage form
GB0607534D0 (en) * 2006-04-13 2006-05-24 Univ London Pharmacy Colonic drug delivery formulation
WO2008028193A2 (fr) * 2006-09-01 2008-03-06 Pharmion Corporation Formulations orales d'analogues de cytidine administrées dans le côlon
EP2073698B1 (fr) * 2006-09-29 2015-09-09 Medimetrics Personalized Drug Delivery B.V. Capteur de seuil miniaturisé
GB2442202A (en) 2006-09-30 2008-04-02 Morvus Technology Ltd Vermin poison
WO2008122967A2 (fr) 2007-04-04 2008-10-16 Sigmoid Pharma Limited Composition pharmaceutique orale
US20090036414A1 (en) * 2007-08-02 2009-02-05 Mutual Pharmaceutical Company, Inc. Mesalamine Formulations
US20090269405A1 (en) * 2008-04-08 2009-10-29 Appian Labs, Llc Enzyme mediated delivery system
GB0808537D0 (en) 2008-05-12 2008-06-18 Archimedes Dev Ltd Compositions
NZ623495A (en) 2008-05-15 2015-08-28 Celgene Corp Oral formulations of cytidine analogs and methods of use thereof
PT2365802T (pt) 2008-11-11 2017-11-14 Univ Texas Microcápsulas de rapamicina e utilização para o tratamento de cancro
US9283211B1 (en) 2009-11-11 2016-03-15 Rapamycin Holdings, Llc Oral rapamycin preparation and use for stomatitis
US11974971B2 (en) 2011-01-07 2024-05-07 Anji Pharmaceuticals Inc. Compositions and methods for treating metabolic disorders
US11759441B2 (en) 2011-01-07 2023-09-19 Anji Pharmaceuticals Inc. Biguanide compositions and methods of treating metabolic disorders
US20120276056A1 (en) * 2011-04-26 2012-11-01 Wieslaw Janusz Bochenek Method for Use of Biologic Agents Including Live or Dormant Forms of Bacteria and other organisms in Treating Infections, Inflammation and Other Diseases of Distal Small Intestine and Large Intestine
BR112014016808B1 (pt) 2012-01-06 2022-01-11 Anji Pharma (Us) Llc Uso de um composto de biguanida para a fabricação de um medicamento para baixar os níveis de glicose no sangue e para o tratamento de um distúrbio do metabolismo de glicose
AU2013240289B2 (en) * 2012-03-29 2018-01-25 Therabiome, Llc Gastrointestinal site-specific oral vaccination formulations active on the ileum and appendix
US20140066837A1 (en) 2012-07-26 2014-03-06 Ronald L. Moy Skin care compositions and methods
WO2014160328A1 (fr) 2013-03-13 2014-10-02 The Board Of Regents Of The University Of Texas System Inhibiteurs de mtor pour la prévention de la croissance de polypes intestinaux
NZ711298A (en) 2013-03-14 2021-07-30 Therabiome Llc Targeted gastrointestinal tract delivery of probiotic organisms and/or therapeutic agents
EP2981289A1 (fr) * 2013-04-05 2016-02-10 Polichem SA Utilisation de pidotimodes pour traiter la maladie inflammatoire de l'intestin
SG11201506480VA (en) 2013-04-05 2015-10-29 Polichem Sa Use of pidotimod to treat irritable bowel syndrome
EP3089737B1 (fr) 2013-12-31 2021-11-03 Rapamycin Holdings, LLC Préparations orales de nanoparticules de rapamycine, et utilisation
US9700544B2 (en) 2013-12-31 2017-07-11 Neal K Vail Oral rapamycin nanoparticle preparations
CN106255508B (zh) * 2014-02-20 2020-07-07 瓦克萨特公司 用于小肠递送的制剂
CA2968049A1 (fr) 2014-04-16 2015-10-22 Rapamycin Holdings, Llc Preparation orale de rapamycine et utilisation pour une stomatite
HUE061382T2 (hu) 2014-08-22 2023-06-28 Celgene Corp Eljárás myeloma multiplex kezelésére immunomoduláló vegyületekkel, antestekkel kombinálva
WO2016200951A1 (fr) * 2015-06-12 2016-12-15 Vaxart, Inc. Formulations pour l'administration dans l'intestin grêle d'antigènes du rsv et des norovirus
CN109562137A (zh) 2015-09-01 2019-04-02 第波生物公司 用于治疗与异常炎性反应有关的病况的方法和组合物
US10588864B2 (en) 2016-03-11 2020-03-17 Gateway Pharmaceuticals LLC Pharmaceutical compositions for colon-specific delivery
CN106380636B (zh) * 2016-08-30 2019-05-14 华南理工大学 一种壳聚糖接枝的抗消化淀粉载体材料及其制备方法和应用
CN108201531A (zh) * 2016-12-19 2018-06-26 湖南尔康湘药制药有限公司 高溶解性磺苄西林钠结肠靶向淀粉胶囊及其制备方法
CA3060026A1 (fr) 2017-04-18 2018-10-25 Jayant Jagannath Khandare Formulation a base de polymere pour la liberation de medicaments et de produits bioactifs au niveau de sites specifiques du git
US20210113479A1 (en) * 2018-05-03 2021-04-22 M.W. Encap Limited Dosage forms for delivery of medicines to the lower gastrointestinal tract
US20230102999A1 (en) 2020-01-10 2023-03-30 First Wave Bio, Inc. Deuterated niclosamide
US10980756B1 (en) 2020-03-16 2021-04-20 First Wave Bio, Inc. Methods of treatment
WO2021188564A1 (fr) 2020-03-16 2021-09-23 First Wave Bio, Inc. Méthodes de traitement de la covid-19 avec un composé de niclosamide
TW202308652A (zh) 2021-04-20 2023-03-01 大陸商江蘇恒瑞醫藥股份有限公司 用於藥物特定遞送的膠囊及其製備方法
US11896719B2 (en) 2022-01-24 2024-02-13 Calliditas Therapeutics Ab Pharmaceutical compositions

Family Cites Families (33)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ZA825384B (en) * 1981-07-31 1983-05-25 Tillott J B Ltd Orally administrable pharmaceutical compositions
US4738724A (en) * 1983-11-04 1988-04-19 Warner-Lambert Company Method for forming pharmaceutical capsules from starch compositions
US4673438A (en) * 1984-02-13 1987-06-16 Warner-Lambert Company Polymer composition for injection molding
US4663308A (en) 1984-07-18 1987-05-05 Medical College Of Ohio Method of use of polymers containing cross-linked azo bonds for releasing therapeutic agents into the lower gastrointestinal tract
US4627851A (en) 1984-10-26 1986-12-09 Alza Corporation Colonic-therapeutic delivery system
US4668517A (en) 1985-04-04 1987-05-26 Norwich Eaton Pharmaceuticals, Inc. Furazolidone dosage form
IL77186A0 (en) * 1985-11-29 1986-04-29 Touitou Elka Pharmaceutical insulin composition
US4945080A (en) * 1987-05-26 1990-07-31 Eli Lilly And Company Dirithromycin metabolite
JP2782691B2 (ja) * 1987-09-29 1998-08-06 ワーナー−ランバート・コンパニー 腸溶製剤の安定化
DE3869337D1 (de) * 1987-11-20 1992-04-23 Greither Peter Kapsel und verfahren zu ihrer herstellung.
DE8715583U1 (de) * 1987-11-24 1988-01-28 Greither, Peter, Kirchberg Kapsel
DE3812799A1 (de) 1988-04-16 1989-10-26 Sanol Arznei Schwarz Gmbh Oral zu verabreichende pharmazeutische zubereitung mit kontrollierter wirkstofffreisetzung und verfahren zu deren herstellung
GB8812490D0 (en) 1988-05-26 1988-06-29 Agricultural & Food Res Delayed release formulations
US5342624A (en) * 1989-02-16 1994-08-30 British Technology Group Ltd. Dispensing device
EP0425699B1 (fr) 1989-05-11 1994-08-17 Chugai Seiyaku Kabushiki Kaisha Preparation orale pouvant etre liberee dans une region appropriee de l'intestin
US5032405A (en) * 1989-09-27 1991-07-16 Warner-Lambert Company Oral pharmaceutical composition for acid sensitive proteinaceous agents
BE1003677A3 (nl) * 1990-01-29 1992-05-19 Schacht Etienne Werkwijze voor het bereiden van azobevattende polymeren en het gebruik ervan als geneesmiddelafgiftesystemen.
IL98087A (en) * 1990-05-04 1996-11-14 Perio Prod Ltd Preparation for dispensing drugs in the colon
DE69229779T2 (de) * 1991-04-19 1999-12-23 Lds Technologies, Inc. Konvertierbare mikroemulsionsverbindungen
KR100274734B1 (ko) * 1991-11-22 2000-12-15 제이코버스 코넬리스 레이서 리제드로네이트 지연-방출성 조성물
DE4236025A1 (de) 1992-10-24 1994-04-28 Merck Patent Gmbh Orale Arzneiformen
DE69427466T2 (de) 1993-02-26 2002-04-25 The Procter & Gamble Company, Cincinnati Bisacodyl dosierungsform
US5651983A (en) * 1993-02-26 1997-07-29 The Procter & Gamble Company Bisacodyl dosage form for colonic delivery
US5656290A (en) 1993-02-26 1997-08-12 The Procter & Gamble Company Bisacodyl dosage form with multiple enteric polymer coatings for colonic delivery
US5686105A (en) 1993-10-19 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form with multiple enteric polymer coatings for colonic delivery
DE69425453T2 (de) 1993-04-23 2001-04-12 Novartis Ag, Basel Wirkstoffabgabevorrichtung mit gesteuerter Freigabe
DE4329503A1 (de) 1993-09-01 1995-03-02 Galenik Labor Freiburg Gmbh Pharmazeutische Präparate zur gezielten Behandlung von Morbus Crohn und Colitis Ulcerosa
EP0724441A1 (fr) 1993-10-19 1996-08-07 The Procter & Gamble Company Forme galenique picosulfate
US5514663A (en) 1993-10-19 1996-05-07 The Procter & Gamble Company Senna dosage form
US5707648A (en) * 1993-11-17 1998-01-13 Lds Technologies, Inc. Transparent liquid for encapsulated drug delivery
US5482718A (en) 1994-03-23 1996-01-09 Hoffmann-La Roche Inc. Colon-targeted delivery system
US5686106A (en) 1995-05-17 1997-11-11 The Procter & Gamble Company Pharmaceutical dosage form for colonic delivery
US5891474A (en) * 1997-01-29 1999-04-06 Poli Industria Chimica, S.P.A. Time-specific controlled release dosage formulations and method of preparing same

Also Published As

Publication number Publication date
ATE204751T1 (de) 2001-09-15
FI965154A (fi) 1997-02-20
EP0810857B1 (fr) 2001-08-29
WO1995035100A1 (fr) 1995-12-28
US20010026807A1 (en) 2001-10-04
NO315686B1 (no) 2003-10-13
NO965436D0 (no) 1996-12-18
US6228396B1 (en) 2001-05-08
GB9412394D0 (en) 1994-08-10
DE69522475D1 (de) 2001-10-04
FI965154A0 (fi) 1996-12-20
CA2193481A1 (fr) 1995-12-28
DE69522475T2 (de) 2002-05-08
EP0810857A1 (fr) 1997-12-10
PT810857E (pt) 2001-12-28
AU2746095A (en) 1996-01-15
DK0810857T3 (da) 2001-10-08
ES2162922T3 (es) 2002-01-16
AU688060B2 (en) 1998-03-05
NO965436L (no) 1996-12-18
CA2193481C (fr) 2001-03-20
JP2986217B2 (ja) 1999-12-06
JPH09510478A (ja) 1997-10-21

Similar Documents

Publication Publication Date Title
FI118626B (fi) Kooloniin annettava lääkekoostumus
EP0825854B1 (fr) Forme galenique pharmaceutique pourvue de plusieurs couches polymeres enterosolubles, destinee a etre liberee dans le colon
AU757343B2 (en) Enteric and colonic delivery using HPMC capsules
EP0827398B1 (fr) Forme pharmaceutique destinee a etre liberee dans le colon
EP1916995B1 (fr) Système de distribution pulsatile commandé par le ph, procédés de préparation et utilisation
EP1059918A1 (fr) Nouvelle forme posologique
AU679852B2 (en) Stabilized composition for oral administration of peptides
US20050249800A1 (en) System for release in lower gastrointestinal tract
JP2967492B2 (ja) 腸内適所放出経口製剤
CA2271569C (fr) Forme galenique pharmaceutique comportant des revetements enteriques polymeres multiples pour administration dans le colon
AU732210B2 (en) Colonic delivery of weak acid drugs
Kendall et al. The role of polymers in solid oral dosage forms
JP3122478B2 (ja) 下部消化管放出型経口製剤
Nykänen Development of multiple-unit oral formulations for colon-specific drug delivery using enteric polymers and organic acids as excipients
KR100212432B1 (ko) 대장 약물전달 조성물
AU7732496A (en) Pharmaceutical dosage form for colonic delivery
NZ565272A (en) pH-controlled pulsatile delivery system, methods for preparation and use thereof

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: ARCHIMEDES DEVELOPMENT LIMITED

Free format text: ARCHIMEDES DEVELOPMENT LIMITED

FG Patent granted

Ref document number: 118626

Country of ref document: FI

MA Patent expired